Rebalance the autonomic nervous system. Improve heart failure symptoms.
Barostim is an option to improve exercise capacity in the 72% of patients not indicated for CRT
GDMT improves heart failure mortality and morbidity in HFrEF patients, but only shows modest improvement in exercise capacity.1
Barostim rebalances the autonomic nervous system
Barostim’s Baroreflex Activation Therapy works by electrically stimulating carotid baroreceptors which increases baroreflex sensitivity, rebalances the autonomic nervous system and improves heart failure symptoms.
Watch the animation
Baroreflex Activation Therapy
Baroreflex Activation Therapy is delivered by the Barostim NEO, an implantable pulse generator (IPG) designed to deliver continuous electrical stimulation to carotid baroreceptors.
The Barostim System comprises the Barostim NEO IPG, the Carotid Sinus Lead and a simple, intuitive Programmer.
Safe implant procedure
The Barostim System is implanted in a safe surgical procedure where the Carotid Sinus Lead is sutured to the carotid sinus and the Barostim NEO IPG is inserted in a standard device pocket.
Procedures are typically performed on an outpatient basis.
The system contains no hardware in the heart or vasculature.